QQQ   375.47 (+0.76%)
AAPL   148.76 (+1.51%)
MSFT   308.23 (+0.31%)
FB   339.99 (+1.39%)
GOOGL   2,864.74 (+0.32%)
TSLA   864.27 (-0.67%)
AMZN   3,444.15 (-0.08%)
NVDA   222.90 (+0.31%)
BABA   177.00 (+6.10%)
NIO   40.03 (+1.06%)
CGC   14.34 (+8.64%)
GE   104.73 (+0.59%)
AMD   116.33 (-0.09%)
MU   67.57 (+0.46%)
T   25.59 (+1.03%)
F   15.42 (-0.90%)
ACB   7.45 (+7.66%)
DIS   171.18 (+0.02%)
PFE   42.09 (+1.86%)
BA   215.97 (-0.47%)
AMC   40.80 (-5.18%)
QQQ   375.47 (+0.76%)
AAPL   148.76 (+1.51%)
MSFT   308.23 (+0.31%)
FB   339.99 (+1.39%)
GOOGL   2,864.74 (+0.32%)
TSLA   864.27 (-0.67%)
AMZN   3,444.15 (-0.08%)
NVDA   222.90 (+0.31%)
BABA   177.00 (+6.10%)
NIO   40.03 (+1.06%)
CGC   14.34 (+8.64%)
GE   104.73 (+0.59%)
AMD   116.33 (-0.09%)
MU   67.57 (+0.46%)
T   25.59 (+1.03%)
F   15.42 (-0.90%)
ACB   7.45 (+7.66%)
DIS   171.18 (+0.02%)
PFE   42.09 (+1.86%)
BA   215.97 (-0.47%)
AMC   40.80 (-5.18%)
QQQ   375.47 (+0.76%)
AAPL   148.76 (+1.51%)
MSFT   308.23 (+0.31%)
FB   339.99 (+1.39%)
GOOGL   2,864.74 (+0.32%)
TSLA   864.27 (-0.67%)
AMZN   3,444.15 (-0.08%)
NVDA   222.90 (+0.31%)
BABA   177.00 (+6.10%)
NIO   40.03 (+1.06%)
CGC   14.34 (+8.64%)
GE   104.73 (+0.59%)
AMD   116.33 (-0.09%)
MU   67.57 (+0.46%)
T   25.59 (+1.03%)
F   15.42 (-0.90%)
ACB   7.45 (+7.66%)
DIS   171.18 (+0.02%)
PFE   42.09 (+1.86%)
BA   215.97 (-0.47%)
AMC   40.80 (-5.18%)
QQQ   375.47 (+0.76%)
AAPL   148.76 (+1.51%)
MSFT   308.23 (+0.31%)
FB   339.99 (+1.39%)
GOOGL   2,864.74 (+0.32%)
TSLA   864.27 (-0.67%)
AMZN   3,444.15 (-0.08%)
NVDA   222.90 (+0.31%)
BABA   177.00 (+6.10%)
NIO   40.03 (+1.06%)
CGC   14.34 (+8.64%)
GE   104.73 (+0.59%)
AMD   116.33 (-0.09%)
MU   67.57 (+0.46%)
T   25.59 (+1.03%)
F   15.42 (-0.90%)
ACB   7.45 (+7.66%)
DIS   171.18 (+0.02%)
PFE   42.09 (+1.86%)
BA   215.97 (-0.47%)
AMC   40.80 (-5.18%)
NASDAQ:NVIV

InVivo Therapeutics News Headlines

$0.64
0.00 (0.00 %)
(As of 10/19/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.62
$0.65
50-Day Range
$0.59
$0.70
52-Week Range
$0.50
$2.00
Volume319,132 shs
Average Volume2.24 million shs
Market Capitalization$22.03 million
P/E RatioN/A
Dividend YieldN/A
Beta1.37

Media Mentions By Week

InVivo Therapeutics Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

NVIV
News Sentiment

-0.71

0.36

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

NVIV Articles
This Week

0

0

NVIV Articles
Average Week

Get InVivo Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for NVIV and its competitors with MarketBeat's FREE daily newsletter.

InVivo Therapeutics (NASDAQ NVIV) News Headlines Today

SourceHeadline
MarketBeat logoPulmonx (NASDAQ:LUNG) versus InVivo Therapeutics (NASDAQ:NVIV) Critical Comparison
americanbankingnews.com - October 12 at 5:20 PM
finance.yahoo.com logoInVivo Therapeutics Announces Participation at Upcoming H.C. Wainwright Annual Global Investment Conference
finance.yahoo.com - September 9 at 4:17 PM
finance.yahoo.com logoInVivo Therapeutics Announces 75% Target Enrollment Achieved for the INSPIRE 2.0 Spinal Cord Injury Study
finance.yahoo.com - September 8 at 9:14 AM
nasdaq.com logoInVivo Therapeutics Holdings Corp Common Stock (NVIV)
nasdaq.com - August 7 at 10:38 PM
finance.yahoo.com logoInVivo Therapeutics Holdings (NASDAQ:NVIV) Is In A Good Position To Deliver On Growth Plans
finance.yahoo.com - July 19 at 2:21 PM
uk.finance.yahoo.com logoInVivo Therapeutics Announces FDA Acceptance of Preclinical Module in Support of Company’s Complete HDE Submission
uk.finance.yahoo.com - July 13 at 12:46 PM
marketwatch.com logoInVivo Therapeutics Up After FDA Accepts Preclinical Part of Application
marketwatch.com - July 13 at 12:46 PM
finance.yahoo.com logoInVivo Therapeutics Urges All Stockholders to Vote at the 2021 Annual Meeting to Be Held on Friday July 16, 2021
finance.yahoo.com - July 6 at 9:38 AM
finance.yahoo.com logoIs Invivo Therapeutics (NVIV) A Good Stock To Buy Now?
finance.yahoo.com - June 14 at 3:18 AM
nasdaq.com logoIs InVivo Therapeutics Holdings (NASDAQ:NVIV) In A Good Position To Deliver On Growth Plans?
nasdaq.com - April 29 at 12:43 PM
finance.yahoo.com logoInVivo Therapeutics Announces Presentation at Upcoming M Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual Conference
finance.yahoo.com - March 12 at 2:12 PM
finance.yahoo.com logoInVivo Therapeutics Announces Presentation at Upcoming 2021 H.C. Wainwright Global Life Sciences Conference
finance.yahoo.com - March 5 at 12:45 PM
finance.yahoo.com logoWill InVivo Therapeutics Holdings (NASDAQ:NVIV) Spend Its Cash Wisely?
finance.yahoo.com - January 19 at 6:11 PM
fool.com logoInVivo Therapeutics Holdings
fool.com - November 25 at 6:53 PM
finance.yahoo.com logoInVivo Therapeutics Announces Closing of $15.0 Million Public Offering
finance.yahoo.com - October 26 at 7:17 PM
seekingalpha.com logoInVivo Therapeutics under pressure on pricing $15M equity offering
seekingalpha.com - October 22 at 2:34 PM
benzinga.com logoMid-Day Market Update: Crude Oil Rises 2%; InVivo Therapeutics Shares Plummet
benzinga.com - October 22 at 2:34 PM
finance.yahoo.com logoInVivo Therapeutics Announces Pricing of $15.0 Million Public Offering
finance.yahoo.com - October 22 at 9:28 AM
finance.yahoo.com logoInVivo Therapeutics Announces Presentation at the Upcoming H.C Wainwright Virtual Global Investment Conference
finance.yahoo.com - September 11 at 8:41 AM
in.reuters.com logoInVivo Therapeutics Holdings Corp (NVIV.OQ)
in.reuters.com - July 9 at 9:32 PM
markets.businessinsider.com logoInVivo Therapeutics (NVIV) Stock
markets.businessinsider.com - June 17 at 2:35 PM
www.reuters.com logoBRIEF-Invivo Files For Resale Of Up To 1.83 Mln Shares By The Selling Stockholders
www.reuters.com - May 22 at 7:21 PM
www.marketwatch.com logo10-Q: INVIVO THERAPEUTICS HOLDINGS CORP.
www.marketwatch.com - May 15 at 3:11 PM
finance.yahoo.com logoInVivo Therapeutics Announces Closing of $3.0 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
finance.yahoo.com - April 17 at 4:14 PM
www.barrons.com logoInVivo Therapeutics Holdings Corp.
www.barrons.com - March 31 at 10:26 PM
www.reuters.com logoBRIEF-Invivo Therapeutics Announces Pricing Of $7 Mln Public Offering
www.reuters.com - March 6 at 1:28 PM
seekingalpha.com logoInVivo down 56% after pricing equity offering
seekingalpha.com - March 6 at 1:28 PM
finance.yahoo.com logoInVivo Therapeutics Announces Pricing of $7.0 Million Public Offering
finance.yahoo.com - March 6 at 1:28 PM
www.bloomberg.com logoInVivo Therapeutics Holdings Corp
www.bloomberg.com - February 16 at 12:58 PM
www.businesswire.com logo2019 Update of InVivo Therapeutics Corp - Product Pipeline Analysis - ResearchAndMarkets.com
www.businesswire.com - February 13 at 2:12 PM
seekingalpha.com logoInVivo to reverse split shares 1:30
seekingalpha.com - February 3 at 5:57 PM
finance.yahoo.com logoInVivo Therapeutics Announces Reverse Stock Split
finance.yahoo.com - February 3 at 5:57 PM
finance.yahoo.com logoInVivo Therapeutics Announces Closing of Public Offering of Common Stock
finance.yahoo.com - November 22 at 6:25 PM
finance.yahoo.com logoInVivo Therapeutics Announces Pricing of Public Offering of Common Stock
finance.yahoo.com - November 21 at 12:07 PM
finance.yahoo.com logoInVivo Therapeutics Announces Proposed Public Offering of Common Stock
finance.yahoo.com - November 18 at 12:47 PM
finance.yahoo.com logoInVivo Therapeutics Announces Appointment of Robert Rosenthal to Board of Directors
finance.yahoo.com - November 12 at 9:43 AM
finance.yahoo.com logoBiotech CEO found guilty of defrauding investors
finance.yahoo.com - October 29 at 1:52 PM
finance.yahoo.com logoInVivo Therapeutics Announces Publication of CONTEMPO Registry Study Data in Peer-Reviewed Journal Spinal Cord
finance.yahoo.com - July 16 at 8:48 AM
seekingalpha.com logoInVivo postpones shareholder meeting
seekingalpha.com - July 12 at 8:30 AM
finance.yahoo.com logoInVivo Therapeutics Announces Postponement of Annual Meeting
finance.yahoo.com - July 12 at 8:30 AM
finance.yahoo.com logoInVivo Therapeutics Announces Adjournment of Annual Meeting
finance.yahoo.com - June 14 at 11:08 AM
www.bizjournals.com logoFive things you need to know today, and one small step for the media
www.bizjournals.com - May 30 at 8:34 AM
seekingalpha.com logoEnrollment underway in SCI study of InVivo's Neuro-Spinal Scaffold
seekingalpha.com - May 29 at 6:53 PM
finance.yahoo.com logoBob Langer-founded device-maker InVivo starts new trial after patient deaths
finance.yahoo.com - May 29 at 6:53 PM
finance.yahoo.com logoInVivo Therapeutics Announces Enrollment of First Two Patients into the INSPIRE 2.0 Study for the Treatment of Acute Spinal Cord Injury
finance.yahoo.com - May 29 at 8:29 AM
seekingalpha.com logoInVivo up 2% premarket on new Neuro-Spinal Scaffold data
seekingalpha.com - April 17 at 7:22 PM
finance.yahoo.com logoInVivo Therapeutics Announces Presentation of Twelve-Month Results from the INSPIRE Study of the Investigational Neuro-Spinal Scaffold™ in Acute Thoracic Complete Spinal Cord Injury
finance.yahoo.com - April 17 at 7:22 PM
www.marketwatch.com logoInVivo Therapeutics Reports 2018 Year-end Financial Results and Provides Business Update
www.marketwatch.com - April 1 at 8:34 AM
www.streetinsider.com logoForm 424B3 INVIVO THERAPEUTICS HOLD - StreetInsider.com
www.streetinsider.com - January 16 at 5:50 PM
seekingalpha.com logoInVivo Therapeutics appoints new finance chief
seekingalpha.com - January 14 at 10:18 AM
Get InVivo Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for NVIV and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 10/19/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.